Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Akebia Therapeutics EBIT Margin 2013-2025 | AKBA

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Akebia Therapeutics (AKBA) over the last 10 years. The current EBIT profit margin for Akebia Therapeutics as of March 31, 2025 is .
  
Akebia Therapeutics EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2025-03-31 $0.18B $-0.02B -11.96%
2024-12-31 $0.16B $-0.05B -31.88%
2024-09-30 $0.17B $-0.04B -21.18%
2024-06-30 $0.18B $-0.04B -20.57%
2024-03-31 $0.19B $-0.04B -19.25%
2023-12-31 $0.19B $-0.05B -24.23%
2023-09-30 $0.19B $-0.05B -27.84%
2023-06-30 $0.20B $-0.09B -45.27%
2023-03-31 $0.27B $-0.05B -17.71%
2022-12-31 $0.29B $-0.08B -27.30%
2022-09-30 $0.30B $-0.14B -47.12%
2022-06-30 $0.30B $-0.14B -48.81%
2022-03-31 $0.22B $-0.26B -115.77%
2021-12-31 $0.21B $-0.26B -124.53%
2021-09-30 $0.21B $-0.29B -136.19%
2021-06-30 $0.22B $-0.29B -130.77%
2021-03-31 $0.26B $-0.38B -148.84%
2020-12-31 $0.29B $-0.38B -128.57%
2020-09-30 $0.31B $-0.39B -125.32%
2020-06-30 $0.34B $-0.38B -112.94%
2020-03-31 $0.35B $-0.27B -76.92%
2019-12-31 $0.34B $-0.29B -85.42%
2019-09-30 $0.33B $-0.28B -86.50%
2019-06-30 $0.29B $-0.25B -88.50%
2019-03-31 $0.24B $-0.23B -97.87%
2018-12-31 $0.21B $-0.18B -85.58%
2018-09-30 $0.24B $-0.07B -30.54%
2018-06-30 $0.23B $-0.07B -30.40%
2018-03-31 $0.21B $-0.06B -26.57%
2017-12-31 $0.18B $-0.08B -41.76%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.935B $0.160B
Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.271B 31.99
Zoetis (ZTS) United States $73.161B 27.30
Takeda Pharmaceutical (TAK) Japan $48.365B 9.62
Daiichi Sankyo, - (DSNKY) Japan $46.601B 23.88
BeOne Medicines - (ONC) Cayman Islands $29.523B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.150B 0.00
Merck (MKKGY) Germany $17.047B 12.49
Summit Therapeutics (SMMT) United States $14.690B 0.00
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $12.781B 11.31
Neurocrine Biosciences (NBIX) United States $12.310B 42.17
Orion OYJ (ORINY) Finland $10.212B 27.62
IPSEN (IPSEY) France $10.004B 0.00
Corcept Therapeutics (CORT) United States $7.430B 60.40
Stevanato Group S.p.A (STVN) Italy $7.111B 43.48
Madrigal Pharmaceuticals (MDGL) United States $6.563B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.664B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.975B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.870B 10.06
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.429B 13.14
NewAmsterdam Pharma (NAMS) Netherlands $2.269B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.000B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.653B 0.00
Dyne Therapeutics (DYN) United States $1.638B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.512B 0.00
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.246B 0.00
Harrow (HROW) United States $1.112B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.105B 22.11
Enliven Therapeutics (ELVN) United States $1.075B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.06
Avadel Pharmaceuticals (AVDL) Ireland $0.926B 0.00
Ardelyx (ARDX) United States $0.861B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Elite Pharmaceuticals (ELTP) United States $0.718B 0.00
Xeris Biopharma Holdings (XERS) United States $0.680B 0.00
Xencor (XNCR) United States $0.654B 0.00
KalVista Pharmaceuticals (KALV) United States $0.644B 0.00
AleAnna (ANNA) United States $0.592B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Altimmune (ALT) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.550B 11.96
Verve Therapeutics (VERV) United States $0.549B 0.00
Bioventus (BVS) United States $0.544B 13.79
Theravance Biopharma (TBPH) United States $0.535B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.499B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.454B 9.49
Organogenesis (ORGO) United States $0.389B 0.00
Savara (SVRA) United States $0.382B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 9.91
Aquestive Therapeutics (AQST) United States $0.340B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.44
Nanobiotix S.A (NBTX) France $0.252B 0.00
ProKidney (PROK) United States $0.245B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.234B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
OmniAb (OABI) United States $0.217B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Aldeyra Therapeutics (ALDX) United States $0.167B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.146B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 17.41
Fractyl Health (GUTS) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Wellgistics Health (WGRX) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Surrozen (SRZN) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
Inotiv (NOTV) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Klotho Neurosciences (KLTO) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
FibroGen (FGEN) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00